Sultamicillin Tosylate

舒他西林甲苯磺酸盐

Report date: 2023/02/08 20:00:26
NME

Base Information

Drug NameSultamicillin Tosylate
Drug Alias NameSultamicillinum Tosylate对甲苯磺酸舒他西林托西酸舒他西林Sultamicilline Tosylate甲苯磺酸舒他西林 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsPyelonephritisUrinary Tract InfectionsRespiratory Tract Infections +[5] 
Global Approved IndicationsPyelonephritisUrinary Tract InfectionsRespiratory Tract Infections +[5] 
Approved Indications in ChinaPyelonephritisUrinary Tract InfectionsRespiratory Tract Infections +[5] 
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryEUMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncGuangdong Qiling Pharmaceutical Co LtdShenzhen Haibin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPyelonephritisUrinary Tract InfectionsRespiratory Tract Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01CR04
Related LinksWikipediaKEGG